Evaluation of Efficacy and Safety of AVE5530 in Patients With Primary Hypercholesterolemia

NCT00718965 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
826
Enrollment
INDUSTRY
Sponsor class

Stopped AVE5530 in hypercholesterolemia was stopped due to insufficient efficacy

Conditions

Interventions

Sponsor

Sanofi